Improving Efficiency of Care with Cardiac Remote Monitoring
Improving efficiency of cardiac remote monitoring using AI.

Improving efficiency of cardiac remote monitoring using AI.

Remote Monitoring: from Burden to Opportunity https://www.youtube.com/watch?v=K8_aKQeOnfo Talk 1: Why Remote Monitoring can be a Burden – a Physiologist Point of View Mr Matthew Swift, Swindon, UK Talk 2: A Third Party Platform – Opportunity for Research and Current Care Dr. Michael Kuehl, Conventry, UK Talk 3: Remote Monitoring Data – Opportunity for Better Patient Care Through AI Innovation Prof. Niraj Varma, Cleveland, USA

Q&A around AI in healthcare with HTID https://www.youtube.com/watch?v=W5kcZRHGcNs Q&A around AI in heath with Arnaud Rosier – CEO and Founder of Implicity , Karl Neuberger – Partner at Quantametry, and Philippe Menu – CMO of SophiA Genetics For HealthTech Innovation Days (HTID), organized by EIT Health in partnership with HealthTech For Care, 2020 edition.

Implicity – Smart Remote Monitoring https://www.youtube.com/watch?v=_euePnKY5Jk Watch this 3-minute video on our Youtube channel to discover how our platform is THE solution for cardiologists to monitor remotely their patients! Implicity provides remote monitoring and research platform used by electrophysiology centers to deliver better care quality for their patients with connected Cardiac Implantable Electronic Devices. It aggregates discrete data from all CIEDs across vendors and develops cutting edge AI solutions. Implicity tackles the lack of adoption by offering a solution aggregating data from all CIEDs across manufacturers and designed to make the remote clinical workflow more efficient. Implicity’s ambition is to democratize patient remote monitoring in Cardiology and to leverage the power of data to bring digital innovation into Cardiology practices. Implicity is also developing AI-based digital medical devices serving the future of preventive medicine. To ask a demo of our platform, click here: https://bit.ly/3E53k5V

AI for Diagnosis 2020 – Roundtable https://www.youtube.com/watch?v=UdF0YOYxZEE Digital health is enjoying unprecedented momentum. How can we capitalize on this opportunity and make AI-based solutions part of the healthcare future for an enhanced diagnosis? An insightful discussion with experts in the matter: Arnaud Rosier, Alexandre Guenoun, France Schwarz, Damien Gatinel, moderated by Lorenzo Croati on the topic of “AI for Diagnosis – Discussion between Startuppers and a Doctor”. This content was produced in partnership with AI for Health by the company Startup Inside.

Interview with Dr. Arnaud Rosier, CEO of Implicity https://www.youtube.com/watch?v=_hYCkEc4LU0 Dr. Arnaud Rosier, founder and CEO of Implicity, explains how his remote monitoring platform works, highlights Implicity’s added value in the market and shares his vision for the future.

Management of CIEDs with New Remote Monitoring Features: from Standard of Care to AI https://www.youtube.com/watch?v=KKzKUo3YBYQ Management of CIEDs with New Remote Monitoring Features: from Standard of Care to Artificial Intelligence Dr. Suneet Mittal: “Remote monitoring as a standard of care: constraints and challenges” Prof. Niraj Varma: “The impact of AI in managing ILR dataflow” Dr. Arnaud Rosier: “Innovation to transform remote monitoring into an opportunity for clinical research”

Reducing workload and improving patient care with AI-powered Cardiac Remote Monitoring Copy https://www.youtube.com/watch?v=OsTdv-UmZoU Implicity caught up with Prof. Niraj Varma of the Cleveland Clinic at HRS 2021, discussing the value of cardiac remote monitoring and software tools that can help make the process more seamless.

Reducing workload and improving patient care with AI-powered Cardiac Remote Monitoring https://www.youtube.com/watch?v=qXLhvXUXVI4 Reducing workload and improving patient care with AI-powered Cardiac Remote Monitoring Dr. Jagmeet Singh: “Artificial Intelligence to reduce false positives of ILRs: real-life implications” Dr. Suneet Mittal: “A new direction in the management of AF alerts and disconnected patients” Dr. Arnaud Rosier: “The future of remote monitoring and the impact of the Implicity platform”

Join Implicity at EHRA in Paris, France, April 12-14 We are thrilled to announce that Implicity will be exhibiting at the EHRA 2026 Congress, the annual meeting of the European Heart Rhythm Association. This flagship event will take place from April 12 to April 14, 2026, at the Palais des Congrès in Paris, France. EHRA is the world’s leading conference for electrophysiologists, arrhythmologists, and cardiac rhythm management professionals. For Implicity, this event is a homecoming where we share our latest innovations in AI-powered remote monitoring with the global EP community. Driving the Future of Digital Electrophysiology As the volume of data from pacemakers, ICDs, and ILRs continues to grow, the need for intelligent, vendor-neutral platforms has never been greater. Implicity remains dedicated to helping clinical teams move from « data management » to « patient management. » What to Expect at the Implicity Stand: The Power of One Platform: See how we integrate data from all major manufacturers—Abbott, Biotronik, Boston Scientific, Medtronic and Microport—into a single, high-performance dashboard. AI vs. Alert Fatigue: Discover how our CE-marked and FDA-cleared algorithms¹ filter out noise and prioritize clinically relevant events, reducing the workload for overstretched EP labs. Clinical Excellence: We will be presenting updated data and success stories on how remote monitoring improves long-term survival and reduces hospitalizations for heart failure and arrhythmia patients². A « City of Light » Meeting of the Minds The theme for EHRA 2026 focuses on « translating science into action. » This aligns perfectly with Implicity’s goal: taking complex raw data and turning it into actionable clinical insights that prevent adverse events and improve quality of life. « Hosting EHRA in Paris is always special for us. It’s the perfect setting to show how French-born innovation is helping EP teams around the world scale their remote monitoring programs without compromising patient safety. » — Dr. Arnaud Rosier, CEO & Co-founder of Implicity. Plan Your Visit Event: EHRA Congress 2026 Dates: April 12 – 14, 2026 Venue: Palais des Congrès de Paris (Porte Maillot) Connect With Us in Paris Will you be at EHRA 2026? We invite you to skip the lines and book a dedicated time for a demo or a deep dive into our clinical research with one of our experts. Schedule Your EHRA 2026 Demo Here ¹IM007 ILR ECG Analyzer (CE-marked Class I (under MDD) medical device) and SignalHF are FDA-cleared Class II medical devices, see the instructions for use for more information. ²Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.
